Eisai Inc. and Pfizer Inc. are currently sponsoring a clinical research study to find out whether an investigational study drug (donepezil HCL) will benefit children with cognitive impairment associated with Down syndrome.
Do you know someone with:
- Trisomy 21 Down syndrome
- Between the ages of 10 and 17
- Residing in the community with a caregiver and
- Have no unstable health conditions
If so, they may qualify to participate in this study.
Qualified participants will receive all study-related care at no cost and may be reimbursed for reasonable travel expenses.
If someone you know meets the above criteria and they are interested in participating in this clinical research study please see below for contact information: |
